Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Inverse comorbidity in multiple sclerosis: Findings in a complete nationwide cohort

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Illegal cannabis use is common among Danes with multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Multiple sclerosis and cancer incidence: A Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Multiple sclerosis registries in Europe - An updated mapping survey

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The role of gluten in multiple sclerosis: A systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  5. Clinical utility of anti-MOG antibody testing in a Danish cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Illegal cannabis use is common among Danes with multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Infections seem to be more frequent before onset of pediatric multiple sclerosis: A Danish nationwide nested case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Inverse comorbidity is disease occurring at lower rates than expected among persons with a given index disease. The objective was to identify inverse comorbidity in MS.

METHODS: We performed a combined case-control and cohort study in a total nationwide cohort of cases with clinical onset of MS 1980-2005. We randomly matched each MS-case with five population controls. Comorbidity data were obtained from multiple, independent nationwide registries. Cases and controls were followed from January 1977 to the index date, and from the index date through December 2012. We controlled for false discovery rate and investigated each of eight pre-specified comorbidity categories: psychiatric, cerebrovascular, cardiovascular, lung, and autoimmune comorbidities, diabetes, cancer, and Parkinson's disease.

RESULTS: A total of 8947 MS-cases and 44,735 controls were eligible for inclusion. We found no inverse associations with MS before the index date. After the index date, we found a decreased occurrence of chronic lung disease (asthma and chronic obstructive pulmonary disease) (HR 0.80 (95% CI 0.75-0.86, p<0.00025)) and overall cancer (HR 0.88 (95% CI 0.81-0.95, p=0.0005)) among MS-cases.

CONCLUSION: This study showed a decreased risk of cancers and pulmonary diseases after onset of MS. Identification of inverse comorbidity and of its underlying mechanisms may provide important new entry points into the understanding of MS.

Original languageEnglish
JournalMultiple Sclerosis and Related Disorders
Volume10
Pages (from-to)181-186
Number of pages6
ISSN2211-0348
DOIs
Publication statusPublished - Nov 2016

ID: 49829357